Kurumatani H - Search Results

1

Comparison of Pharmacokinetic Profiles of Beraprost Sustained Release in Japanese, Chinese, and Korean Healthy Adult Males.

Nakajo I, Inoue H, Inaba M, Oikawa K, Katashima M, Sawamoto T, Kurumatani H, Shiramoto M. Nakajo I, et al. Among authors: kurumatani h. Clin Drug Investig. 2021 Jun;41(6):549-555. doi: 10.1007/s40261-021-01031-8. Epub 2021 Apr 28. Clin Drug Investig. 2021. PMID: 33913081

2

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial.

Koyama A, Fujita T, Gejyo F, Origasa H, Isono M, Kurumatani H, Okada K, Kanoh H, Kiriyama T, Yamada S. Koyama A, et al. Among authors: kurumatani h. BMC Nephrol. 2015 Oct 16;16:165. doi: 10.1186/s12882-015-0130-5. BMC Nephrol. 2015. PMID: 26475266 Free PMC article. Clinical Trial.

3

The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function.

Shimamura M, Miyakawa J, Doi M, Okada K, Kurumatani H, Mori Y, Oshida K, Nakajo I, Oikawa K, Ushigome F, Miyashita A, Isono M, Miyamoto Y. Shimamura M, et al. Among authors: kurumatani h. J Clin Pharmacol. 2017 Apr;57(4):524-535. doi: 10.1002/jcph.835. Epub 2016 Nov 15. J Clin Pharmacol. 2017. PMID: 27681484 Clinical Trial.

4

Effects of Sustained-Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study Results.

Nakamoto H, Yu XQ, Kim S, Origasa H, Zheng H, Chen J, Joo KW, Sritippayawan S, Chen Q, Chen HC, Tsubakihara Y, Tamai H, Song SH, Vaithilingam I, Lee KW, Shu KH, Hok-King Lo S, Isono M, Kurumatani H, Okada K, Kanoh H, Kiriyama T, Yamada S, Fujita T. Nakamoto H, et al. Among authors: kurumatani h. Ther Apher Dial. 2020 Feb;24(1):42-55. doi: 10.1111/1744-9987.12840. Epub 2019 Jul 28. Ther Apher Dial. 2020. PMID: 31119846 Clinical Trial.

5

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study.

Kurumatani H, Okada K, Origasa H, Fujita T, Isono M, Nakamoto H. Kurumatani H, et al. Ther Apher Dial. 2021 Oct;25(5):551-564. doi: 10.1111/1744-9987.13616. Epub 2021 Feb 21. Ther Apher Dial. 2021. PMID: 33340238 Free PMC article. Clinical Trial.

6

[Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].

Nishio S, Kurumatani H. Nishio S, et al. Among authors: kurumatani h. Nihon Yakurigaku Zasshi. 2001 Feb;117(2):123-30. doi: 10.1254/fpj.117.123. Nihon Yakurigaku Zasshi. 2001. PMID: 11233303 Review. Japanese.

7

Improvement of walking disturbance by beraprost sodium in rat femoral artery occlusion models.

Miyamoto M, Tayama T, Yamaguchi S, Kaneko M, Kurumatani H. Miyamoto M, et al. Among authors: kurumatani h. Eur J Pharmacol. 2006 Sep 18;545(2-3):173-6. doi: 10.1016/j.ejphar.2006.06.050. Epub 2006 Jun 28. Eur J Pharmacol. 2006. PMID: 16890936

8

A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease.

Takenaka M, Iio A, Sato R, Sakamoto T, Kurumatani H; KT-140 Clinical Study Group. Takenaka M, et al. Among authors: kurumatani h. J Vet Intern Med. 2018 Jan;32(1):236-248. doi: 10.1111/jvim.14839. Epub 2017 Nov 13. J Vet Intern Med. 2018. PMID: 29131397 Free PMC article. Clinical Trial.

9

Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.

Tamura M, Kurumatani H, Matsushita T. Tamura M, et al. Among authors: kurumatani h. Prostaglandins Leukot Essent Fatty Acids. 2001 Mar;64(3):197-202. doi: 10.1054/plef.2001.0261. Prostaglandins Leukot Essent Fatty Acids. 2001. PMID: 11334556

10

Beraprost sodium improves survival rates in anti-glomerular basement membrane glomerulonephritis and 5/6 nephrectomized chronic kidney disease rats.

Yamaguchi S, Inada C, Tamura M, Sato N, Yamada M, Itaba S, Okazaki S, Matsuura H, Fujii S, Matsuda F, Goto Y, Mochizuki H, Kurumatani H, Miyamoto M. Yamaguchi S, et al. Among authors: kurumatani h. Eur J Pharmacol. 2013 Aug 15;714(1-3):325-31. doi: 10.1016/j.ejphar.2013.07.032. Epub 2013 Jul 30. Eur J Pharmacol. 2013. PMID: 23911885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters